Legal entity
All 1 tracked stories fall under one category: corporate-law. Eli Lilly is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The tracked stories average 2 original sources each. U.S. District Court for the District of New Jersey appears in 1 tracked Legal story from July 21, 2026.
Last mentioned: Jul 21, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: corporate-law. Eli Lilly is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The tracked stories average 2 original sources each. U.S. District Court for the District of New Jersey appears in 1 tracked Legal story from July 21, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 15 Legal stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering U.S. District Court for the District of New Jersey. Shared-story counts are live from our verified record — not editorial picks.
Lawsuit filed
Novo Nordisk sues Eli Lilly in federal court, alleging misleading advertising.
Cease-and-desist letter
Novo Nordisk sends a formal request to Eli Lilly to stop running or correct certain ads.
High-dose Wegovy approved
Novo Nordisk’s high-dose obesity injection enters the market, achieving weight loss more comparable to Zepbound.
Novo Nordisk alleges Eli Lilly’s comparative advertising for Zepbound relies on outdated clinical data, violating the Lanham Act. The case could redefine how quickly pharma competitors must update ad claims when new drug formulations enter the market.
U.S. District Court for the District of New Jersey is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
